Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Study Investigational Site Nr. 60, Brussels

Novartis Investigational Site Nr. 57, Brussels

Novartis Investigational Site Nr. 55, Antwerp

Novartis Investigational Site Nr. 59, Edegem

Novartis Investigational Site Nr. 56, Hasselt

Novartis Investigational Site Nr. 58, Namur

Novartis Investigational Site Nr. 10, Castellon

Novartis Investigational Site Nr. 11, Almassora

Novartis Investigational Site Nr. 12, Vall D'Uixo

Novartis Investigational Site Nr. 70, Berlin

Novartis Investigational Site Nr. 46, Santiago de Compostela

Novartis Investigational Site Nr. 5, Milan

Novartis Investigational Site Nr. 52, Milan

Novartis Investigational Site Nr. 72, Hamburg

Novartis Investigational Site Nr. 87, Stockelsdorf

Novartis Investigational Site Nr. 88, Itzenhoe

Novartis Investigational Site Nr. 89, Itzenhoe

Novartis Investigational Site Nr. 71, Bremerhaven

Novartis Investigational Site Nr. 6, Novara

Novartis Investigational Site Nr. 49, Oviedo

Novartis Investigational Site Nr. 85, Bielefeld

Novartis Investigational Site Nr. 73, Baunatal

Novartis Investigational Site Nr. 83, Warburg

Novartis Investigational Site Nr. 9, Padua

Novartis Investigational Site Nr. 48, Vigo Pontevedra

Novartis Investigational Site Nr. 86, Wanzleben

Novartis Investigational Site Nr. 78, Mönchengladbach

Novartis Investigational Site Nr. 79, Heiligenhaus

Novartis Investigational Site Nr. 81, Bochum

Novartis Investigational Site Nr. 17, Valencia

Novartis Investigational Site Nr. 24, Valencia

Novartis Investigational Site Nr. 15, Valencia

Novartis Investigational Site Nr. 18, Valencia

Novartis Investigational Site Nr. 19, Valencia

Novartis Investigational Site Nr. 16, Valencia

Novartis Investigational Site Nr. 21, L'Eliana

Novartis Investigational Site Nr. 23, Valencia

Novartis Investigational Site Nr. 25, Catarroja

Novartis Investigational Site 14, Sagunto

Novartis Investigational Site Nr. 80, Kleve Materborn

Novartis Investigational Site Nr. 82, Münster

Novartis Investigational Site Nr. 75, Bramsche

Novartis Investigational Site Nr. 7, Florence

Novartis Investigational Site Nr. 61, Mainz

Novartis Investigational Site Nr. 69, Aschaffenburg

Novartis Investigational Site Nr. 64, Oberstenfeld

Novartis Investigational Site Nr. 66, Welzheim

Novartis Investigational Site Nr. 65, Bretten

Novartis Investigational Site Nr. 67, Schweigen

Novartis Investigational Site Nr. 62, Kehl

Novartis Investigational Site Nr. 68, Bad Saulgau

Novartis Investigational Site Nr. 90, Erfurt

Novartis Investigational Site Nr. 95, Červený Kostelec

Novartis Investigational Site Nr. 93, Hradec Králové

Novartis Investigational Site Nr. 94, Pardubice

Novartis Investigational Site Nr. 96, Jindřichův Hradec

Novartis Investigational Site Nr. 2, London

Novartis Investigational Site Nr. 1, Oxford

Novartis Investigational Site 3, Bristol

Novartis Investigational Site Nr. 4, Exeter